U.S. markets closed

RegeneRx Biopharmaceuticals, Inc. (RGRX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2750-0.0050 (-1.79%)
At close: 3:39PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/1/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
35.72M33.39M59.38M53.11M42.06M
Enterprise Value 3
36.59M33.99M60.19M53.65M42.21M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
465.09434.33770.29686.44541.45
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
476.681.77k3.14k2.80k2.20k
Enterprise Value/EBITDA 7
-29.16-113.51-207.08-191.33-109.76

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-33.33%
S&P500 52-Week Change 331.83%
52 Week High 30.8200
52 Week Low 30.1800
50-Day Moving Average 30.2900
200-Day Moving Average 30.3678

Share Statistics

Avg Vol (3 month) 357.87k
Avg Vol (10 day) 333.33k
Shares Outstanding 5133.55M
Implied Shares Outstanding 6N/A
Float 104.74M
% Held by Insiders 149.46%
% Held by Institutions 10.17%
Shares Short (Nov 29, 2010) 419.19k
Short Ratio (Nov 29, 2010) 40.15
Short % of Float (Nov 29, 2010) 40.05%
Short % of Shares Outstanding (Nov 29, 2010) 40.03%
Shares Short (prior month Oct 28, 2010) 429.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,635.98%

Management Effectiveness

Return on Assets (ttm)-159.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)76.76k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)71.84k
EBITDA N/A
Net Income Avi to Common (ttm)-1.52M
Diluted EPS (ttm)-0.0110
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)207.61k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.07M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.58
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-982.21k
Levered Free Cash Flow (ttm)-520.97k